physiology and pathophysiology of katp channels in the pancreas and cardiovascular system: a review
TRANSCRIPT
Physiology and pathophysiology of KATP channels in the pancreas
and cardiovascular system
A review
Susumu Seino*
Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba 260-8670, Japan
Received 14 November 2002; accepted 18 November 2002
Abstract
KATP channels are present in pancreatic and extrapancreatic tissues such as heart and smooth muscle, and display diverse molecular
composition. They contain two different structural subunits: an inwardly rectifying potassium channel subunit (Kir6.x) and a sulfonylurea
receptor (SURX). Recent studies on genetically engineered Kir6.2 knockout mice have provided a better understanding of the physiological
and pathophysiological roles of Kir6.2-containing KATP channels. Kir6.2/SUR1 has a pivotal role in pancreatic insulin secretion. Kir6.2/
SUR2A mediates the effects of KATP channels openers on cardiac excitability and contractility and contributes to ischemic preconditioning.
However, controversy remains on the physiological properties of the KATP channels in vascular smooth muscle cells. Kir6.1 knockout mice
exhibit sudden cardiac death due to cardiac ischemia, indicating that Kir6.1 rather than Kir6.2 is critical in the regulation of vascular tone.
This article summarizes current understanding of the physiology and pathophysiology of Kir6.1- and Kir6.2-containing KATP channels.
D 2003 Elsevier Science Inc. All rights reserved.
Keywords: ATP; Sulfonylurea; Inward rectifier
1. Introduction
Adenosine triphosphate (ATP)-sensitive K + channels
are found in a variety of tissues, including pancreatic
b-cells, central neurons, as well as cardiac, smooth, and
skeletal muscle (Ashcroft & Gribble, 1999; Ashford,
Sturgess, Trout, Gardner, & Hales, 1988; Davis, Standen,
& Stanfield, 1991; Nichols & Lederer, 1991; Quayle,
Nelson, & Standen, 1997). They regulate many cellular
functions by coupling the metabolic state of the cell to
its electrophysiological membrane potential (Ashcroft,
1988). As a result of recent progress in molecular
biology and electrophysiology, KATP channel structure
and diversity is increasingly being understood. Cloning,
sequencing, and functional analyses of KATP channel
genes reveal different molecular composition of the
various KATP channels (Seino, 1999). It is now well
known that plasma membrane KATP channels consist of
two different structural subunits: an inwardly rectifying
potassium channel subunit, which forms the pore (Kir6.x),
and a sulfonylurea receptor (SURX) as the regulatory
subunit (Aguilar-Bryan et al., 1998). The subunits
assemble as a hetero-octamer with 4:4 stoichiometry
(Inagaki et al., 1995). Based on sequence similarity,
inwardly rectifying K + channels (Kir6.x) are divided
into seven subfamilies, including Kir6.1 and Kir6.2
(Inagaki et al., 1995). The regulatory sulfonylurea recep-
tor (SUR) subunit is encoded by two different genes,
SUR1 and SUR2. SUR2A and SUR2B are splice var-
iants of SUR2 (Inagaki et al., 1996; Isomoto et al.,
1996). It has been shown that pancreatic b-cell KATP
channels consist of SUR1 and Kir6.2, whereas KATP
channels in cardiomyocytes and skeletal muscle comprise
SUR2A and Kir6.2 (Seino, Iwanaga, Nagashima, &
Miki, 2000) (see Fig. 1). In contrast, vascular and
nonvascular smooth muscle KATP channels are formed
by a coupling of the SUR2B subunit with either Kir6.2
or Kir6.1 (Yamada et al., 1997). KATP channels can be
nonselectively blocked in nonpancreatic tissues by some
sulfonylureas, like glibenclamide, and activated by K +
1056-8727/03/$ – see front matter D 2003 Elsevier Science Inc. All rights reserved.
PII: S1056 -8727 (02 )00274 -X
* Tel.: +81-43-226-2187; fax: +81-43-221-7803.
E-mail address: [email protected] (S. Seino).
Journal of Diabetes and Its Complications 17 (2003) 2–5
channel-opening drugs such as pinacidil, nicorandil, and
diazoxide (Ashcroft & Gribble, 2000; Beech, Zhang,
Nakao, & Bolton, 1993).
2. Diverse roles of KATP channels
Much insight into the physiological and pathophysio-
logical roles of KATP channels in various tissues has been
gained from genetically engineered mice. A mouse model
expressing a dominant negative form of Kir6.2 in the
pancreatic b-cells and a mouse model lacking Kir6.2
(Kir6.2 knockout mice) (Miki et al., 1998) allow direct
determination of the physiological roles of the KATP
channels in the pancreas (Seino et al., 2000). It has been
shown that Kir6.2/SUR1 channels are critical in both
glucose- and sulfonylurea-induced insulin secretion and
that they play a crucial role in b-cell survival and islet-
cell architecture. In order to clarify the functional role of
the Kir6.2 subunit in cardiac and vascular tissue, Suzuki
et al. (2001) further studied mice generated by knockout
(KO) of the Kir6.2 gene. The effects of pharmacological
K + -channel openers (pinacidil and diazoxide) on cardiac
and vascular smooth muscle KATP channels were deter-
mined in these mice. The results show that Kir6.2/SUR2A
is essential for mediating the depression of cardiac
excitation and contraction induced by K + -channel open-
ers. In contrast, no effect on vasodilation was observed in
response to K + -channel openers, indicating that Kir6.2
plays no discernable role in the artery.
3. Kir6.1-containing potassium channels:
current understanding
The electrophysiological and pharmacological prop-
erties of Kir6.2-containing K + channels have been char-
acterized in detail in reconstitution studies (Inagaki et al.,
1995, 1996) and native tissues (Suzuki et al., 2001,
2002). However, the physiological role of Kir6.1-contain-
ing KATP channels is poorly understood. Yamada et al.
(1997) showed that coexpression of Kir6.1 and SUR2B
produces a K + current that is activated by nucleoside
diphosphates such as uridine diphosphate (UDP) and
inhibited by the sulfonylurea glibenclamide. These prop-
erties were found to be similar to those observed for
ATP-sensitive K + channels in vascular smooth muscle
(Beech et al., 1993; Standen et al., 1989). However, it
remained to be shown whether Kir6.1 was an essential
component of KATP channels.
4. Kir6.1-containing potassium channels:
recent advances
To further clarify the physiological role of Kir6.1-con-
taining channels, mice lacking the gene encoding Kir6.1
(Kcnj8) were generated (Miki et al., 2002). Surprisingly,
these mice exhibited a high rate of sudden cardiac death
between 30 and 40 days after birth.
On the electrocardiogram, spontaneous ST-segment
elevation followed by a series of severe atrioventricular
(AV) blocks were documented in these cases, whereas no
such abnormality was recorded in Kir6.2 knockout mice.
Sudden cardiac death has been shown to be associated
with genetic electrophysiological abnormalities in K +,
Na + , and Ca2 + channels that affect the depolarization
and repolarization of cardiomyocytes (Keating & Sangui-
netti, 2001). In contrast, in mice lacking the gene for
Kir6.1, none of these abnormalities appeared in the plasma
membrane of cardiomyocytes. It also was shown that
cardiomyocytes of Kir6.1 knockout mice display normal
electrophysiological properties; the K +-channel opener
pinacidil produced an increase in outward current and a
shortened action potential duration. These effects were
reversed by glibenclamide, a KATP-channel blocker. The
effects were similar in wild-type and Kir6.1 knockout
mice. Accordingly, it is not likely that Kir6.1 is a subunit
of the plasma membrane KATP channels in cardiomyocytes.
These findings also indicate that the AV block in Kir6.1
knockout mice is not due to plasma membrane channel
dysfunction in cardiomyocytes. An alternative explanation
for the AV block and sudden cardiac death in Kir6.1
knockout mice is myocardial ischemia caused by impaired
regulation of vascular tonus of the coronary arteries.
Indeed, it has been shown that Kir6.1 knockout mice lack
a vasodilation response to K +-channel openers such as
pinacidil, both in vivo (blood pressure decrease) and in
vitro (relaxation of aortic rings) (Miki et al., 2002). Wild-
type mice as well as Kir6.2 knockout mice, in contrast,
exhibit similar vasodilation responses to K +-channel open-
ers, the effects of which were blocked by glibenclamide
(Suzuki et al., 2001). Intravenous injection of methylergo-
Fig. 1. Types of KATP channel.
S. Seino / Journal of Diabetes and Its Complications 17 (2003) 2–5 3
metrine directly triggers vasoconstriction-induced elevation
in ST segment and cardiac death in Kir6.1 knockout mice
but not in wild-type mice. The lack of vasodilation
response to K + -channel openers and the abnormal
response to a vasoconstrictor in Kir6.1 knockout mice
indicate that this KATP-channel subunit plays a critical role
in the regulation of vascular tone, especially in the
coronary arteries.
The most striking finding in Kir6.1 knockout mice is
severe, lethal AV block due to spontaneous coronary
spasm (Miki et al., 2002) (see Fig. 2). This closely
resembles Prinzmetal angina in humans, a form of
unstable angina associated with hypercontractility of
epicardial coronary arteries (Prinzmetal, Kennamer, Mer-
liss, Wada, & Bor, 1959). Prinzmetal angina is charac-
terized by ST-segment elevation during the anginal attack
or by induction of coronary spasm using ergot alkaloids
or acetylcholine (Maseri, 1987). As the sudden cardiac
death in Kir6.1 knockout mice was associated with
spontaneous ST-segment elevation and the ergot alkaloid
methylergometrine provoked significant elevations of the
ST segments both in vivo and in vitro in these samples,
Kir6.1 knockout mice may well be a suitable animal
model of Prinzmetal angina. The regulatory subunit of
Kir6.1 is the sulfonylurea receptor SUR (most likely
SUR2B). Sulfonylureas are widely used in the treatment
of Type 2 diabetes, so it is important to learn the
different effects of the agents of this therapeutic class
on the Kir6.1/SUR2B channel.
5. Conclusion
Studies using Kir6.2 and Kir6.1 knockout mice have
been essential in determining the physiological roles of
KATP channels. The role of Kir6.2/SUR1 in pancreatic
b-cells and Kir6.2/SUR2A in cardiomyocytes is well
established. Less clear, however, are the subunits which
constitute the KATP channel in vascular smooth muscle
tissue. Recent work on Kir6.1 knockout mice indicates
that Kir6.1, rather than Kir6.2, is required in the regu-
lation of vascular tone, in association with SUR2B. The
importance of the differing effects of the various sulfo-
nylureas on the different extrapancreatic KATP channels
is suggested.
References
Aguilar-Bryan, L., Clement, J. P. IV, Gonzales, G., Kunjilwar, K.,
Babenko, A., & Bryan, J. (1998). Towards understanding the assembly
and structure of K-ATP channels. Physiological Reviews, 78, 227–245.
Ashcroft, F. M. (1988). Adenosine-triphosphate-sensitive potassium chan-
nels. Annual Review of Neuroscience, 11, 97–118.
Ashcroft, F. M., & Gribble, F. M. (1999). ATP-sensitive K+ channels and
insulin secretion: their role in health and disease. Diabetologia, 42,
903–919.
Ashcroft, F. M., & Gribble, F. M. (2000). Tissue-specific effects of sulfo-
nylureas; lessons from studies of cloned KATP channels. Journal of
Diabetes and its Complications, 14, 192–196.
Ashford, M. L. J., Sturgess, N. C., Trout, N. J., Gardner, N. J., &
Hales, C. N. (1988). Adenosine-50triphosphate-sensitive ion channels
in neonatal rat cultured central neurons. Pfluegers Archiv, 412,
297–304.
Beech, D. J., et al. (1993). K channel activation by nucleotide diphosphates
and its inhibition by glibenclamide in vascular smooth muscle cells.
British Journal of Pharmacology, 110, 573–582.
Davis, N. W., Standen, N. B., & Stanfield, P. R. (1991). ATP-dependent
potassium channels of muscle cells: their properties, regulation, and
possible functions. Journal of Bioenergetics and Biomembranes, 23,
509–535.
Inagaki,N.,Gonoi,T.,Clement, J. P. IV,Namba,N., Inazawa, J.,Gonzales,G.,
Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995). Reconstruction of
I KATP: an inward rectifier subunit plus the sulfonylurea receptor.
Science, 270, 1166–1170.
Inagaki, N., et al. (1996). A family of sulfonylurea receptors determines the
pharmacological properties of ATP-sensitive K+ channels. Neuron, 16,
1011–1017.
Isomoto, S., et al. (1996). A novel sulfonylurea receptor forms with BIR
(Kirk6.2) a smooth muscle type ATP-sensitive K+ channel. Journal of
Biological Chemistry, 271, 24321–24324.
Keating, M. T., & Sanguinetti, M. C. (2001). Molecular and cellular mech-
anisms of cardiac arrhythmias. Cell, 104, 569–580.
Maseri, A. (1987). Role of coronary artery spasm in symptomatic and silent
myocardial ischemia. Journal of the American College of Cardiology, 9,
249–262.
Miki, T., et al. (1998). Defective insulin secretion and enhanced insulin
action in KATP channel-deficient mice. Proceedings of the National
Academy of Sciences of the United States of America, 95,
10402–10406.
Miki, T., et al. (2002). Mouse model of Prinzmetal angina by disruption of
the inward rectifier Kir6.1. Nature Medicine, 8 (5), 466–472.
Nichols, C. G., & Lederer, W. J. (1991). Adenosine triphosphate-sensitive
potassium channels in the cardiovascular system. American Journal of
Physiology, 261, H1675–H1686.
Prinzmetal, M., et al. (1959). Angina pectoris: 1. A variant of angina
pectoris: preliminary report. American Journal of Medicine, 27,
375–388.
Quayle, J. M., Nelson, M. T., & Standen, N. B. (1997). ATP-sensitive and
inwardly-rectifying potassium channels in smooth muscle. Physiologi-
cal Reviews, 77, 1165–1232.
Seino, S. (1999). ATP-sensitive potassium channels: a model of heteromul-
Fig. 2. Spontaneous ST elevation and AV block on ECG in Kir6.1
knockout mouse.
S. Seino / Journal of Diabetes and Its Complications 17 (2003) 2–54
timetric potassium channel/receptor assemblies. Annual Review of Phys-
iology, 61, 337–362.
Seino, S., et al. (2000). Diverse of KATP channels learned from Kir6.2
genetically engineered mice. Diabetes, 49, 311–318.
Standen, N. B., et al. (1989). Hyperpolarizing vasodilators activate
ATP-sensitive K+ channels in arterial smooth muscle. Science,
245, 177–180.
Suzuki, M., et al. (2001). Functional roles of cardiac and vascular ATP-
sensitive potassium channels clarified by Kir6.2-knockout mice. Circu-
lation Research, 88, 570–577.
Suzuki, M., et al. (2002). Role of sarcolemmal KATP channels in cardio-
protection against ischemia/reperfusion injury in mice. Journal of Clin-
ical Investigation, 109, 509–516.
Yamada, M., et al. (1997). Sulfonylurea receptor 2B and Kir6.1 form a
sulfonylurea sensitive but ATP-insensitive K+ channel. Journal of
Physiology (London), 499.3, 715–720.
S. Seino / Journal of Diabetes and Its Complications 17 (2003) 2–5 5